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Abstract: Objective: To predict response rate and validity of a population-based HIV prevalence survey in Barbados 
using oral fluid, and the method of sample identification preferred by participants. 
Methods: Persons age 18 to 35 randomly selected from the voters’ register to participate in a study of the prevalence of 
chlamydia and gonorrhoea (STI) were invited to answer a questionnaire. 
Results: Of 496 persons selected for the STI study, 88 did not participate, and a further 10 did not answer the 
questionnaire, leaving 398 respondents. 329 persons or 66% (60% men, 73% women, p = 0.003) of the original 496 
persons said that they would be willing to take part in an HIV survey using oral fluid. 
People indicating willingness to take part in an HIV survey did not differ significantly from non-respondents and those 
indicating unwillingness to participate by a number of demographic and STI risk factors including age, education level, 
partnership status, number of partners, condom use, drug use, and STI infection status. 
For persons willing to participate in a HIV survey, confidential linked sample identification was acceptable to 99.0% 
(95% CI  ± 1.0), and unlinked identification to 1.6% (95% CI  ± 1.3). 
Conclusion: The HIV prevalence estimated by a linked survey would have a reasonable response rate and be valid, as 
likelihood of participation is not related to infection risk. 
Keywords: HIV, saliva, population surveillance, prevalence, sample identification. 
INTRODUCTION 
  Between 1984 when the first HIV/AIDS case was 
diagnosed in Barbados, and December 2005, the cumulative 
number of cases was 3110 (1889 males and 1086 females), 
70% of persons were between 20 to 49 years of age at 
diagnosis, and 1283 deaths were recorded [1]. It is estimated 
that 97% of women attending public antenatal clinics 
between January and March 2003 had voluntary testing [2]. 
In 2002 prevalence in antenatal women was 1.2%, and from 
this the estimated prevalence for Barbados was 1.75% [3]. 
  In many countries HIV prevalence is estimated by 
extrapolation of data derived from sentinel groups, 
particularly antenatal women. However, population-based 
surveys done in India and in several African countries have 
shown that these estimates can significantly overestimate 
prevalence [4,5]. But in South Africa a national HIV survey 
gave an age adjusted prevalence similar to that derived from 
antenatal surveillance [6]. 
  For the purposes of surveillance different methods can be 
used to label specimens [7]. These can be divided into two 
categories: a) unlinked anonymous tests with or without   
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informed consent, and b) linked testing, which can be 
confidential or anonymous. With unlinked anonymous tests 
personal identifiers are not collected, and it is not possible to 
trace persons with positive tests. Blood routinely collected 
for another purpose might be tested for HIV without 
informed consent, but in a population-based HIV prevalence 
survey, informed consent is needed from each respondent. 
With linked testing pre and post-test counselling would be 
necessary to conform to the usual standard in Barbados. 
With confidential linked testing a code or name can be used 
to identify the specimen, and the person can be informed of 
the result. With anonymous linked testing the specimen is 
labelled with a code not linked to any personal identifiers, 
and only the person can link this code to the result. 
  Oral fluid samples as collected by the OraSure device [8] 
would be more suitable for community-based studies than 
blood tests, as they are easier to collect, do not require the 
disposal of sharps, are less of a transmission hazard, and 
remain stable at room temperature for 3 weeks. Positive tests 
can also be reconfirmed by a second ELISA and by Western 
Blot. Studies conducted in the Caribbean [9, 10] gave a 
sensitivity and specificity comparable to those achieved with 
blood samples. Manufacturers of the Vironostika enzyme 
immunoassay report a sensitivity and specificity of 99% 
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  A national HIV prevalence survey would be expensive, 
labour intensive, time consuming and require careful 
planning. It would therefore be useful to know in advance if 
the population would find participating in an HIV prevalence 
study acceptable, if the sample agreeing to testing would be 
unbiased, and what method of identification of specimens 
would be preferred by the population. 
METHODS 
  Eighteen to 35 year olds were randomly selected from the 
voters’ register of the St. Michael South East electoral 
district, Barbados to determine the prevalence of Chlamydia 
trachomatis and Neisseria gonorrhoea [12]. Respondents 
completed a questionnaire and provided a first void urine 
sample to a field worker for CT/NG testing using PCR. 
Respondents were then invited to participate in this survey 
on HIV testing. Separate written consent was obtained. 
  The study area has an estimated population 8450 persons 
(1731 males and 1719 females between the ages of 18 and 
35 years), or 3% of the Barbados population. It is 
approximately one mile east of the capital Bridgetown, and 
contains all socio-economic strata [13]. 
  Respondents were asked whether they would participate 
in an HIV survey using an oral fluid sample and to choose 
between a) confidential linked testing using the name, b) 
confidential linked testing using a code, and c) unlinked 
anonymous testing where no one including the researchers 
would be able to match the result to the individual. 
Respondents were informed that the first two options would 
allow them to receive the test result, but the use of a code 
would increase confidentiality, as only one person in the 
research team would be able to match it to the name. 
Data Analysis 
  SPSS 10.0, and the Creative Systems Research sample 
size calculator [14] were used to analyse data. The Chi-
square test was used to determine the statistical significance 
of associations between the categorical variables. Fishers 
Exact test was used when numbers were small. Non-
normally distributed continuous variables were tested for 
significance using the Mann-Whitney U test. P< 0.05 by 
two-tailed test was considered statistically significant. 
  Ethical approval was obtained from the Ministry of 
Health, Barbados. 
RESULTS 
  Of 496 persons (248 males and 248 females) who were 
randomly selected to participate in the study to determine the 
prevalence of Chlamydia trachomatis and Neisseria 
gonorrhoea, 88 (52 males and 36 females) declined to take 
part. Of the remaining 408 persons, 10 (6 males and 4 
females) did not participate in the survey on HIV testing. 
This gave a total of 98 non-responders with a median age 26 
years (interquartile range [IQR] 10), and 398 respondents, 
median age 25 years (IQR 10), (p = 0.753). 
  Of the 398 respondents, 69 (17%) answered that they 
would not participate in an HIV survey as described to them,  
leaving 329 who would participate. Assuming that none of 
the persons who refused to take part in the Chlamydia/ 
Gonorrhoea study would have agreed to take part in the HIV 
survey, 329 persons or 66.3% (95% CI ± 3.9) of the original 
496 persons said that they were willing to take part in an 
HIV survey using oral fluid. Women were more likely than 
men (p = 0.03) to indicate willingness to participate in a 
study (Table 1). There was not a significant difference in 
response by other characteristics. 
  Of the 322 persons indicating a preference of sample 
identification, 309 (96.0%, 95%CI  ± 2.0%) were willing to 
have a code used to identify the sample. Of these 297 
(92.2%, 95%CI  ± 2.8) selected the use of a code exclusively. 
Twenty persons (6.2%, 95%CI  ± 2.5) (10 males and 10 
females) were willing to have their names used to identify 
the samples. Of these 10 (3.1+1.8%) indicated they would be 
also be willing to use a code. Five persons (1.6%, 95%CI  ± 
1.3) (3 males and 2 female) were willing to use an unlinked 
anonymous sample. Of these, 2 would also be willing to use 
a code. In total, 319 (99.1%, 95% CI  ± 1.0) would be 
willing to use some form of linked testing (code or name). 
DISCUSSION 
  Sixty-six percent of adults between 18 to 35 years of age 
were willing to provide an oral fluid sample for HIV testing. 
This is similar to the 65% response for a household survey 
using oral fluid in South Africa [15], but less than the 82% 
response with finger stick blood in India [4]. All persons 
who would participate, had provided urine in a preceding 
Chlamydia/Gonorrhoea prevalence survey, which shows that 
population surveys for sexually transmitted infection are 
feasible in Barbados [12]. However, 18% of those who 
provided urine were not willing to provide oral fluid, 
suggesting some additional stigma and fear, or perceived 
lack of benefit from HIV testing. 
  HIV infection is not evenly distributed in any population. 
The prevalence depends on the risk behaviours of groups 
within that population. Men were significantly less likely 
than women to indicate willingness to participate (Table 1). 
This is the case in many surveys. However potential risk 
factors such as age, educational level, income, lifetime 
number of partners, condom use at last intercourse, current 
infection with Chlamydia and/or Gonorrhoea, and a history 
of drug use were not associated with willingness to have a 
HIV test. A survey therefore could produce a valid estimate 
of HIV prevalence, as there is no indication that refusal to 
participate is associated with risk for HIV infection. 
  Linked confidential testing using a code to identify the 
specimen was the preferred choice of almost everyone. This 
labelling method is used for routine HIV testing in Barbados, 
while the patient’s name is used on every other type of 
laboratory specimen. Rejection of the unlinked anonymous 
option suggests that most persons are interested in knowing 
their HIV status. This has implications for planning a future 
study, as pre and post-test counselling would be needed. 
  Only one district was surveyed, with the assumption that 
non-responders in the preceding Chlamydia/Gonorrhoea  
 86    The Open AIDS Journal, 2010, Volume 4  Adams and Carter 
Table 1.  Willingness to Participate in a Survey Using Oral Fluid to Estimate HIV Prevalence by Category 
 
Category 
Number (%) of Respondents in 
Each Category
& (n = 408 Eligible 
Unless Otherwise Indicated) 
Would Do HIV Test 
Number (% ± 95% CI) 
p by Chi Square 
(Unless Otherwise 
Indicated) 
Gender 
Male 
Female 
(n = 496) 
248(50) 
248 (50) 
 
149 (60 ± 6) 
180 (73 ± 5) 
 
0.003 
Age (years) 
18 to 20 
21 to 35 
(n = 496) 
111 (22) 
385 (78) 
 
73 (66 ± 8) 
256 (67 ± 4) 
 
0.791* 
Education 
Secondary or less 
Polytechnic  
Tertiary 
 
247 (63) 
59 (15) 
90 (23) 
 
201 (81 ± 5) 
43 (73 ± 11) 
74 (82 ± 8) 
 
 
0.295 
Partnership Status 
Married 
Common law 
Single/separated  
 
34 (9) 
45 (11) 
318 (80) 
 
25 (74 ± 14) 
37 (82 ± 11) 
257 (81 ± 4) 
 
 
0.564 
Monthly Income 
<$500 
500-999 
1000-1499 
1500 or more 
 
117 (33) 
75 (21) 
59 (16) 
108 (30) 
 
92 (79 ± 7) 
62 (83 ± 8) 
49 (80 ± 10) 
86 (80 ± 7) 
 
 
 
0.854 
Health Care Source 
Private GP
@ 
Polyclinic  
(n = 352) 
174 (51) 
170 (49) 
 
141 (81 ± 6) 
138 (81 ± 6) 
 
 
0.973 
Last Medical Consultation 
<6 months 
>6months/can’t recall 
 
185 (46) 
218 (54) 
 
149 (81 ± 5) 
176 (81 ± 5) 
 
 
0.961 
Age of Sexual Debut 
<15 years 
15 to 17 years 
>17 years 
(n = 383) 
68 (19) 
196 (54) 
98 (27) 
 
55 (81 ± 9) 
156 (80 ± 5) 
85 (87 ± 6) 
 
 
0.255* 
Lifetime No. of Sex Partners 
0 
1-2 
3 or more 
 
25 (6.7) 
81 (21.7) 
267 (71.6) 
 
20 (80 ± 15) 
61 (84 ± 8) 
216 (81 ± 4) 
 
 
0.792* 
Number of Partners in Last 12 Months 
0  
1 
2 or more 
 
55 (14) 
292 (73) 
56 (14) 
 
44 (80 ± 10) 
240 (82 ± 4) 
42 (75 ± 11) 
 
 
0.448 
Chlamydia and/or Gonorrhoea Infected 
Yes 
No  
(n = 397) 
50 (13) 
347 (87) 
 
43 (86 ± 9) 
277 (80 ± 4) 
 
0.302 
Condom Use Last Intercourse
#  
Yes 
No 
(n = 319) 
151 (53) 
136 (47) 
 
124 (82 ± 6) 
115 (85 ± 6) 
 
 
0.580 
Condom Use Last Intercourse: Commercial Partner 
Yes 
No 
(n = 22) 
14 (67) 
7 (33) 
 
11 (79 ± 20) 
5 (72 ± 31) 
 
 
1.00** 
Smokes Cigarettes 
Yes 
No 
 
51 (13) 
352 (87) 
 
41 (80 ± 10) 
283 (80 ± 4) 
 
1.000 
Used Marijuana 
Yes 
No 
 
112 (28) 
289 (72) 
 
91 (81 ± 7) 
232 (80 ± 4) 
 
0.825 
Used Cocaine 
Yes 
No 
 
4 (1) 
396 (99) 
 
4 (100 ± 9) 
319 (81 ± 4) 
 
1.000** 
&For gender and age all 98 non-responders were assumed to be unwilling to do an HIV test and were included in the analysis (n  =  496 eligible). For all other categories 10 non-
responders to this survey were included where data was available from a preceding survey. 
*p using the Mann-Whitney U test on the continuous variable. 
@General practitioner. 
#Condom use with a partner not being lived with. 
**Fisher’s exact test. HIV Population Survey Feasibility in Barbados  The Open AIDS Journal, 2010, Volume 4    87 
study [12] would also be non-responders for a HIV study. 
These limitations need to be taken into account when 
interpreting this study. Barbados is however a small island, 
and much more homogenous than India or South Africa 
where surveys have been successfully completed. An actual 
survey would need to be extended beyond the 18 to 35 years 
age group. In a survey where the test is actually being 
offered, the response rate may differ from the situation in 
this survey where the test was hypothetical. 
CONCLUSIONS 
  These findings should reduce concerns that linked 
surveys result in biased findings because those at most risk 
of disease will refuse to take part. A population based 
prevalence study has the potential of providing unbiased 
population based information to health planners, and 
valuable information to the individuals who participate. 
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